Skip to main content
Table of Contents
Print

What Evidence Exists on Long-Term Cannabis Use and Panic Disorder Outcomes? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Investigating long-term cannabis for panic outcomes in panic disorder provides insights into both potential benefits and risks for patients. Reviewing chronic use studies, longitudinal research, and data on tolerance & safety helps clinicians and patients understand the implications of sustained cannabis use. Understanding long-term cannabis for panic outcomes guides informed decisions about ongoing therapy. 

Evaluating Long-Term Effects 

Careful analysis of long-term cannabis for panic outcomes ensures that evidence is applied safely and effectively in clinical practice. 

Chronic Use Studies 

Chronic use studies examine repeated or prolonged cannabis exposure and its impact on panic frequency, severity, and overall patient functioning. 

Longitudinal Research 

Longitudinal research tracks patients over extended periods, providing data on symptom trajectory, efficacy, and potential cumulative effects. 

Tolerance & Safety 

Research on tolerance & safety assesses whether prolonged use leads to diminished effectiveness, dependency, or adverse events, guiding responsible administration. 

In conclusion, long-term cannabis for panic outcomes shows promising but variable results. Reviewing chronic use studies, longitudinal research, and tolerance & safety considerations helps clinicians and patients optimise treatment while mitigating potential risks. 

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories